They found that people taking GLP-1s were less likely to have anemia, blood clots in veins, low levels of white blood cells called neutrophils, low blood platelet count, sepsis, nausea and vomiting, fatigue, cardiomyopathy, and neuropathy after chemotherapy
Hims & Hers has widened access to FDA-approved GLP-1 options through supported prescription and pharmacy routes
These can include any of the following: Age: It is more common for people over age 65 to have kidney or liver issues, and this can affect how the medication is metabolized or processed in the body and how much of it becomes available to use
What's next
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients (Journal of the American College of Cardiology)
Clinical evidence shows that most patients adjust within 48 weeks, though individual responses vary significantly based on genetics and IBS subtype